Provided by Tiger Trade Technology Pte. Ltd.

NanoViricides

1.26
-0.0400-3.08%
Post-market: 1.290.0300+2.38%19:38 EDT
Volume:205.15K
Turnover:261.55K
Market Cap:32.13M
PE:-3.07
High:1.30
Open:1.30
Low:1.25
Close:1.30
52wk High:2.23
52wk Low:0.8500
Shares:25.50M
Float Shares:24.90M
Volume Ratio:0.35
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4100
EPS(LYR):-0.4071
ROE:-101.46%
ROA:-55.53%
PB:3.70
PE(LYR):-3.10

Loading ...

NanoViricides - Files to Offer up to $50 Mln in Securities - SEC Filing

THOMSON REUTERS
·
Jun 06

Top Premarket Gainers

MT Newswires Live
·
May 27

Analysts Are Bullish on These Healthcare Stocks: Evogene (EVGN), NanoViricides (NNVC)

TIPRANKS
·
May 27

NanoViricides says NV-387 oral gummies ready to ship to DRC for Phase II mpox trial amid Ebola outbreak

Reuters
·
May 26

NanoViricides Highlights NV-387 Strategy for Ebola Outbreak

TIPRANKS
·
May 21

NanoViricides says NV-387 candidates expected to work against Congo Bundibugyo Ebola strain

Reuters
·
May 21

NanoViricides Completes $2 Million Registered Direct Offering

TIPRANKS
·
May 21

NanoViricides closes US$2 million registered direct offering priced at US$1.5 share

Reuters
·
May 19

EXPLAINER-What do we know about the Bundibugyo strain of the Ebola virus?

Reuters
·
May 19

NanoViricides emphasizes need for Ebolavirus antiviral drug

TIPRANKS
·
May 18

NanoViricides prices US$2 million registered direct offering with warrants

Reuters
·
May 15

NanoViricides Q3 FY26 net loss narrows to $1.99 million; R&D expenses rise to $1.29 million

Reuters
·
May 15

NanoViricides says hantavirus incident highlights need for antiviral drugs

TIPRANKS
·
May 11

NanoViricides says FDA grants orphan drug designation to NV-387 for measles treatment

Reuters
·
May 04

NanoViricides measles virus treatment granted FDA orphan status

TIPRANKS
·
Apr 29

NanoViricides says NV-387 can help control spread of measles

TIPRANKS
·
Apr 21

NanoViricides applies for FDA orphan, rare pediatric designations for measles drug NV-387

Reuters
·
Apr 21

NanoViricides files FDA rare pediatric disease drug designation application for measles drug NV-387

Reuters
·
Apr 08

NanoViricides files application for RPDD for NV-387 with U.S. OPDD

TIPRANKS
·
Apr 07